"Nivolumab: …
NIVOLUMAB: Immune Checkpoint…
Nivolumab for Recurrent Head and Neck-https://t.co/NqaFWDEXEt
再発頭頸部扁平上皮癌に対するニボルマブ(オプジーボ®) 《このCheckMate 141試験により頭頸部癌へも承認間近! 》
This page shows the most recent Facebook posts that mention this research output.
Click here to find out how to access more activity, including 2 additional Facebook posts.